1816 |
DOPAMINE RECEPTOR D5 |
DRD5 |
DBDR |
DRD1B |
DRD1L2 |
126453 |
3026 |
ENSG00000169676 |
OTTHUMG00000128489 |
P21918 |
DRD5_HUMAN |
D(1B) DOPAMINE RECEPTOR |
D(5) DOPAMINE RECEPTOR |
D1BETA DOPAMINE RECEPTOR |
Dopamine D5 receptor |
D(1B) DOPAMINE RECEPTOR (D(5) DOPAMINE RECEPTOR) (D1BETA DOPAMINE RECEPTOR). [SOURCE:UNIPROT/SWISSPROT;ACC:P21918] |
D5R |
T46828 |
1536 |
Transmembrane Helix Count | 6 |
Target Subclass | GPCR |
Target Subclass | Rhodopsin |
Target Main Class | Receptors |
Interpro Acc | IPR000276 |
Uniprot Evidence | 1: Evidence at protein level |
Interpro Short Name | 7TM_GPCR_Rhodpsn |
Human Readable Name | DRUGGABLE GENOME |
Human Readable Name | G PROTEIN COUPLED RECEPTOR |
Interpro Type | Family |
Uniprot Status | Swiss-Prot |
Interpro Name | GPCR, rhodopsin-like, 7TM |
Target Class | Receptors |
Gene Biotype | PROTEIN_CODING |
G PROTEIN COUPLED RECEPTOR |
DRUGGABLE GENOME |
antagonist (inhibitory) |
Trial Name | - |
Novel drug target | Established target |
antagonist (inhibitory) |
Trial Name | - |
Novel drug target | Established target |
n/a |
Novel drug target | Established target |
Trial Name | etilevodopa, TV-1203 |
agonist (activating) |
Direct Interaction | yes |
Mechanism of Interaction | Dopamine receptor agonist |
n/a |
Trial Name | V-1512, CHF-1512,Levomet Complex, Sirio |
Novel drug target | Established target |
agonist (activating) |
Trial Name | entacapone/levodopa/carbidopa,Stalevo |
Novel drug target | Established target |
Trial Name | levodopa + carbidopa,Duodopa |
agonist (activating) |
Mechanism of Interaction | Dopamine receptor agonist |
Direct Interaction | yes |
antagonist (inhibitory) |
Mechanism of Interaction | Dopamine receptor antagonist |
Direct Interaction | yes |
antagonist (inhibitory) |
Trial Name | olanzapine,Zyprexa, Zypadhera, Zyprexa Relprevv |
Novel drug target | Established target |
Trial Name | Olanzapine/fluoxetine combination,Symbyax (Zyprexa/Prozac) |
antagonist (inhibitory) |
Mechanism of Interaction | Dopamine receptor antagonist |
Direct Interaction | yes |
DRD5 | Ensembl Gene Name |
Gene Biotype | PROTEIN_CODING |
1816 | Entrez Gene Id |
DRD5_HUMAN | Uniprot Id |
DRD5 | Gene Symbol |
Transmembrane Helix Count | 6 |
Target Subclass | GPCR |
Target Subclass | Rhodopsin |
DRD5 | Gene Symbol |
Target Class | Receptors |
Target Subclass | GPCR |
Target Subclass | Rhodopsin |
DRD5 | Display Id |
D(1B) DOPAMINE RECEPTOR (D(5) DOPAMINE RECEPTOR) (D1BETA DOPAMINE RECEPTOR). [SOURCE:UNIPROT/SWISSPROT;ACC:P21918] | Description |
ENSG00000169676 | Ensembl Gene Id |
Human Readable Name | DRUGGABLE GENOME |
DRUGGABLE GENOME |
DRD5_HUMAN | Uniprot Id |
ENSG00000169676 | Ensembl Gene Id |
1816 | Entrez Gene Id |
Interpro Acc | IPR000276 |
Uniprot Evidence | 1: Evidence at protein level |
Interpro Short Name | 7TM_GPCR_Rhodpsn |
G PROTEIN COUPLED RECEPTOR, DRUGGABLE GENOME |
1816 | Entrez Gene ID |
1536 | CIViC Gene ID |
ENSG00000169676 | Gene Symbol |
DRD5 | Ensembl Id |
DRUGGABLE GENOME |
DRD1L2 | GENE_SYMBOL |
DRD5 | GENE_SYMBOL |
D(1B) dopamine receptor | UNIPROT |
DRD1B | GO Gene Synonym |
DRD1L2 | GO Gene Synonym |
G PROTEIN COUPLED RECEPTOR |
1816 | Gene ID |
DBDR | dGene Synonym |
DRD1B | dGene Synonym |
G PROTEIN COUPLED RECEPTOR |
D5R | TTD Gene Abbreviation |
T46828 | TTD Target ID |